Most Active Series A Investors in Life Sciences — Europe

1 High-Tech Gründerfonds Management GmbH £300k – £20M 88 deals since 2022 · 5 in last 12 mo recorded 2 British Growth Fund £5M – £20M 32 deals since 2022 · 5 in last 12 mo recorded 3 Oxford Innovation EIS Growth Fund £150k – £400k 13 deals since 2022 · 5 in last 12 mo recorded 4 Maven Capital Partners £1M – £20M 18 deals since 2022 · 4 in last 12 mo recorded 5 Mercia Asset Management PLC £500k – £10M 9 deals since 2022 · 0 in last 12 mo recorded 6 Ananda Impact Ventures £5M – £15M 8 deals since 2022 · 0 in last 12 mo recorded 7 Gresham House Ventures £3M – £20M 8 deals since 2022 · 0 in last 12 mo recorded 8 SCOR Ventures £1M – £10M 7 deals since 2022 · 0 in last 12 mo recorded 9 Longwall Venture Partners LLP £1M – £10M 5 deals since 2022 · 0 in last 12 mo recorded 10 Apollo Health Ventures £1M – £20M 3 deals since 2022 · 0 in last 12 mo recorded 11 Astia £1M – £10M 2 deals since 2022 · 0 in last 12 mo recorded International · active in Europe 12 Cambridge Innovation Capital Undisclosed 0 deals since 2022 · 0 in last 12 mo recorded 13 NG Northern Gritstone Undisclosed 0 deals since 2022 · 0 in last 12 mo recorded 14 Elaia Partners £300k – £8M 0 deals since 2022 · 0 in last 12 mo recorded 15 Lansdowne Partners Venture Fund Undisclosed 0 deals since 2022 · 0 in last 12 mo recorded